First Commonwealth Financial’s Boston Scientific BSX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$289K Buy
6,612
+146
+2% +$6.76K 0.04% 235
2026
Q2
$276K Hold
6,466
– – 0.04% 239
2026
Q1
$406K Sell
6,466
-41
-0.6% -$3.28K 0.06% 198
2025
Q4
$620K Buy
6,507
+13
+0.2% +$1.28K 0.1% 158
2025
Q3
$634K Sell
6,494
-401
-6% -$41.5K 0.11% 153
2025
Q2
$741K Hold
6,895
– – 0.16% 125
2025
Q1
$696K Buy
6,895
+4,426
+179% +$446K 0.16% 124
2024
Q4
$221K Buy
+2,469
New +$217K 0.05% 207

Other funds holding BSX

First Commonwealth Financial's BSX Position: Q3 2026 in Review

First Commonwealth Financial increased its Boston Scientific (BSX) stake by 2.3% in Q3 2026, buying an estimated $6.76K and bringing the position to 6,612 shares worth $289K. The position accounts for 0.04% of the portfolio, ranked #235.

First Commonwealth Financial first reported a position in BSX in Q4 2024 and has held it in 8 quarters since. The position peaked at $741K in Q2 2025. 1,274 funds tracked by Wall St. Rank hold BSX as of Q3 2026.

  • First Commonwealth Financial held 6,612 shares of Boston Scientific worth $289K as of Q3 2026.
  • First Commonwealth Financial bought 146 Boston Scientific shares in Q3 2026, an estimated $6.76K.
  • Boston Scientific made up 0.04% of First Commonwealth Financial's portfolio in Q3 2026, its #235 holding.
  • First Commonwealth Financial first reported a position in Boston Scientific in Q4 2024 and has held it in 8 quarters since.
  • First Commonwealth Financial's Boston Scientific position peaked at $741K in Q2 2025.
  • 1,274 funds tracked by Wall St. Rank held Boston Scientific as of Q3 2026.

Based on First Commonwealth Financial's 13F filing for Q3 2026, filed 13 Nov 2026.